South Africa Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

South Africa Clinical Nutrition for Diabetes Care Market Analysis

$ 3999

The South Africa Clinical Nutrition for Diabetes Care Market was valued at $13.98 Mn in 2023 and is predicted to grow at a CAGR of 6.01% from 2023 to 2030, to $21.03 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Abbott Nutrition, Cipla, and Novo Nordisk among others.

ID: IN10ZAPH566 CATEGORY: Pharmaceuticals GEOGRAPHY: South Africa AUTHOR: Avantika Gupta

Buy Now

South Africa Clinical Nutrition for Diabetes Care Market Executive Summary

The South Africa Clinical Nutrition for Diabetes Care Market is at around $13.98 Mn in 2023 and is projected to reach $21.03 Mn in 2030, exhibiting a CAGR of 6.01% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients maintain blood sugar control, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies include Novo Nordisk, Sanofi is known for its extensive portfolio of medications, including those essential for diabetes care. Nestlé Health Science, Pfizer Inc., and Aspen Pharmacare are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

South Africa Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Prevalence of Diabetes: As per the International Diabetes Federation, diabetes prevalence in South Africa has reached 11.3%, the highest in Africa. This growing burden of diabetes is a major driver for the clinical nutrition market in South Africa and there is an increasing acknowledgment of the value of nutrition therapy in diabetes treatment and the significance of clinical nutrition products and services in improving patient outcomes.

Rising Obesity and Unhealthy Lifestyles: Rapid urbanization in South Africa has led to the adoption of unhealthy, energy-dense diets and physical inactivity, contributing to the obesity epidemic. Obesity is a major contributor to the type 2 diabetes epidemic, accounting for 87% of cases in South Africa.

Increasing Healthcare Expenditure: The South African government has significantly increased healthcare spending, with expenditure reaching about $15.02 Bn annually. The government has briefly launched a Diabetes Prevention Programme to integrate diabetes interventions into a culturally relevant context. These investments and initiatives are expected to improve access to comprehensive diabetes care.

Market Restraints

High Cost of Specialized Products: Diabetes-specific clinical nutrition solutions are more expensive than regular nutritional supplements and conventional foods. The high cost of these products can limit access for patients, especially those from low-income households and areas with inadequate medical resources. This highlights the economic burden associated with the high cost of specialized therapeutic nutrition products in diabetes care.

Socioeconomic Disparities: Unequal access to healthcare resources and healthy food options disproportionately affects low-income communities. This can make it difficult for these populations to benefit from clinical nutrition interventions. Challenges in the healthcare system, such as limited access to specialized diabetes clinics and registered dietitians, also impede the delivery of comprehensive clinical nutrition services.

Limited Awareness and Education: There is a need to increase awareness about the importance of proper nutrition in diabetes management among both patients and healthcare providers in South Africa. Lack of education can hinder the utilization of clinical nutrition therapies.

Regulatory Landscape and Reimbursement Scenario

South African Health Products Regulatory Authority (SAHPRA): SAHPRA is responsible for regulating health products in South Africa. They ensure the safety and efficacy of these products for diabetic patients. Dietetic Society of South Africa (DSSA) is the professional body representing registered dietitians in South Africa. They play a crucial role in developing and implementing personalized nutrition plans for diabetic patients. The DSSA sets standards for the practice of dietetics, ensuring patients receive qualified advice.

The public healthcare system in South Africa, known as the National Health Insurance (NHI), currently has limited coverage for specialized clinical nutrition products for diabetes management. The NHI primarily focuses on providing basic healthcare services, with limited funding allocated for comprehensive diabetes care. The private healthcare insurance sector in South Africa offers varying levels of coverage for clinical nutrition products and services related to diabetes care.

Competitive Landscape

Key Players

Here are some of the major key players in the South Africa Clinical Nutrition for Diabetes Care Market:

Novo Nordisk
Sanofi
Abbott Nutrition
Nestlé Health Science
Cipla
Aspen Pharmcare
Adcock Ingram
Ascendis Health
Roche
Eli Lilly

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

South Africa Clinical Nutrition for Diabetes Care Market Segmentation

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feedback Formulas

By Stage

Adult
Paediatric

By Distribution Channel

Online
Retail
Institutional Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.